Skip to content
Back to Guavy Wire
Stocks

Microsoft's AI Diagnostic System Crushes Human Physicians in Medical Case Challenge

Instruments
MSFT
Share

Microsoft's AI diagnostic system has made headlines for its impressive accuracy in solving difficult medical cases. In June 2025, the company reported that its experimental diagnostic orchestrator, paired with OpenAI's o3 model, correctly solved as many as 85.5% of 304 exceptionally difficult medical cases adapted from the New England Journal of Medicine.

The results were released as a preprint and have since been revised to reflect new data. In November 2025, the maximum accuracy of the AI system was reported at 84.5%, while physicians averaged 36.1% on the same cases. The system's performance was tested on a controlled, text-based benchmark, not on real patients.

The benchmark, called SDBench, consisted of 304 consecutive clinicopathological conference cases published between 2017 and 2025. These cases were selected for their difficulty and rarity, making the exercise useful for testing diagnostic breadth but also limiting its relevance to everyday clinical practice.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc